Cancer and Thrombosis: from Phlegmasia Alba Dolens to Transgenic Mice

• References

• 1 Trousseau A. Phlegmasia alba dolens. Lectures on clinical medicine, delivered at the Hôtel-Dieu, Paris. London: New Sydenham Society; 1872: 281-295
• 2 Sproul EE. Carcinoma and venous thrombosis: the frequency of association of carcinoma in the body or tail of the pancreas with multiple venous thrombosis. Am J Cancer 1938; 34: 566-585
• 3 Donati MB, Poggi A. Malignancy and haemostasis. Br J Haematol 1980; 44: 173-182
• 4 Bini A, Mesa-Tejada R, Fenoglio JJ, Kudryk B, Kaplan KL. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies. Lab Invest 1989; 60: 814-821
• 5 Prandoni P, Lensing AW A, Biiller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S, Noventa F, ten-Cate JW. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-1133
• 6 Monreal M, Lafoz E, Casals A, Inaraja L, Montserrat E, Ma Callejas J, Martorell A. Occult cancer in patients with deep venous thrombosis: a systematic approach. Cancer 1991; 67: 541-545
• 7 Rickies FR, Levine MN, and Edwards RI. Hemostatic alterations in cancer patients. Cancer Metastasis Reviews 1992; 11: 237-248
• 8 Falanga A, Ofosu F A, Cortellazzo S, Delaini F, Consonni R, Caccia R, Longatti S, Maran D, Rodeghiero F, Pogliani E, Marassi A, D’Angelo A, Barbui T. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery. Briti sh Journal of Haematology 1993; 85: 745-750
• 9 Falanga A, Barbui T, Rickies FR, Levine MN. Guidelines for clotting studies in cancer patients. Throm Haemostas 1993; 70: 540-542
• 10 Levine MN, Gent M, Hirsh J, Arnold A, Goodyear MD, Hryniuk W, De Pauw S. The thrombogenic effect of anti-cancer drug therapy in women with stage II breast cancer. N Engl J Med 1988; 318: 404-407
• 11 Barbui T, Finazzi G, Donati MB, Falanga A. Antiblastic therapy and thrombosis. In: Thrombosis: an update. Scientific Press; Florence: 1992: 305-314
• 12 Levine M, Hirsh J, Gent M, Arnold A, Warr D, Falanga A, Samosh M, Bramwell V, Pritchard KI, Stewart D, Goodwin P. Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 1994; 343: 886-889
• 13 Donati MB, Semeraro N. Cancer cell procoagulants and their pharmacological modulation. Haemostasis 1984; 14: 422-129
• 14 Colucci M, Delaini F, De Beilis Vitti G, Locati D, Poggi A, Semeraro N, Donati MB. Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency. Biochem Pharmacol 1983; 32: 1689-1691
• 15 Donati MB, Gambacorti Passerini C, Casali B, Falanga A, Vannotti P, Fossati G, Semeraro N, Gordon SG. Cancer procoagulant in human tumor cells: evidence from melanoma patients. Cancer Res 1986; 46: 6471-6474
• 16 Falanga A, Bolognese D’Alessandro AP, Casali B, Roncaglioni MC, Donati MB. Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics. Int J Cancer 1987; 39: 774-777
• 17 Bani MR, Falanga A, Alessio MG, Radice E, Consonni R, Giavazzi R, Donati MB. Blood coagulation changes in nude mice bearing human colon carcinomas. Int J Cancer 1992; 50: 75-79
• 18 Gordon SG, Hashiba V, Poole MA, Cross BA, Falanga A. A cysteine proteinase procoagulant from amnionchorion. Blood 1985; 66: 1261-1266
• 19 Gordon SG, Cross BA. An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker. Cancer Res 1990; 50: 6229-6234
• 20 Falanga A, Alessio MG, Donati MB, Barbui T. A new procoagulant in acute leukemia. Blood 1988; 870: 875
• 21 Alessio MC, Falanga A, Consonni R, Bassan R, Minetti B, Donati MB, Barbui T. Cancer procoagulant in acute lymphoblastic leukemia. Eur. J.Haematol 1990; 45: 78-81
• 22 Donati MB, Falanga A, Consonni R, Alessio MG, Bassan R, Buelli M, Catani L, Pogliani E, Gugliotta L, Masera G, Barbui T. Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity. Thromb Haemostas 1990; 64: 11-16
• 23 Falanga A, Consonni R, Marchetti M, Mielicki WP, Rambaldi A, Lanotte M, Gordon SG, Barbui T. Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid. Leukemia 1994; 8: 156-159
• 24 Falanga A, lacoviello L, Evangelista V, Belotti D, Consonni R, D’Orazio A, Robba L, Donati MB, Barbui T. Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia on All-trans-retinoic acid. Blood. 1995 in press
• 25 Poggi A, Stella M, Donati MB. The importance of blood cell-vessel wall interactions in tumor metastasis. Bailliere Clinical Haematology 1993; 6: 731-752
• 26 Zacharski LR, Donati MB, Rickies FR. Registry of clinical trials of antithrombotic drugs in cancer: second report. Thromb Haemostas 1993; 70: 357-360
• 27 Poggi A, Bellelli E, Castelli MP, Marinacci R, Rella C, lacoviello L, Erickson LA, Donati MB, Bini A. Fibrinolysis and metastasis: the role of plasminogen activator inhibitor-1 (PAI-1) in a model of transgenic mice. Thromb Haemostas 1993; 69: 775
• 28 Pintucci G, lacoviello L, Castelli MP, Amore C, Evangelista V, Cerletti C, Donati MB. Cathepsin G-induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes. J Lab Clin Med 1993; 122: 69-79
• 29 Kolpakov V, D’Adamo MC, Salvatore L, Amore C, Mironov A, lacoviello L, Donati MB. Neutrophil derived cathepsin G induces potentially thrombogenic changes in human endothelial cells: a scanning electron mocroscopy study in static and dynamic conditions. Thromb Haemostas 1994; 72: 140-145
• 30 lacoviello L, Kolpakov V, Salvatore L, Amore C, Pintucci G, de Gaetano G, Donati MB. Detachment of matrix-bound PAI-1 by neutrophil derived cathepsin G and subsequent cytoskeleton rearrangement in human endothelial cells. Atheroscler Thrombos. 1995 in press
• 31 Giavazzi R, Garofalo A, Bani MR, Abbate M, Ghezzi P, Boraski D, Mantovani A, Dejana E. Interleukin-1 -induced augmentation of experimental metastases from human melanoma in nude mice. CancerRes 1990; 50: 4771-4775
• 32 Bani MR, Garofalo A, Scanziani E, Giavazzi R. Effect of interleukin-16 on metastasis formation in different tumor systems. J Natl Cancer Inst 1991; 83: 119-123